Spots Global Cancer Trial Database for Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer

Official Title: Randomized Phase IIb Preprostatectomy Study of Dietary Supplementation With Soy and Biomarkers of Prostate Cancer Risk and Progression

Study ID: NCT00345813

Conditions

Prostate Cancer

Interventions

soy isoflavones

soy protein isolate

placebo

Study Description

Brief Summary: RATIONALE: Dietary supplementation with soy may keep prostate cancer from growing in patients planning to undergo surgery. PURPOSE: This randomized phase II trial is studying a soy supplement to see how well it works compared to a placebo in treating patients undergoing surgery for localized prostate cancer.

Detailed Description: OBJECTIVES: Primary * Compare the effect of dietary supplementation with soy vs placebo on biomarkers of cell cycle regulation, proliferation, differentiation, apoptosis, and signaling pathways in patients with localized prostate cancer scheduled to undergo radical prostatectomy. Secondary * Compare the toxicity and side effects of these regimens in these patients. * Compare the dietary patterns of these patients. OUTLINE: This is a prospective, randomized study. Patients are randomized to 1 of 2 treatment arms. * Arm I: Patients receive oral soy supplementation daily for 4 weeks. * Arm II: Patients receive oral placebo supplementation daily for 4 weeks. Patients undergo radical prostatectomy within 21 days after completion of soy or placebo supplementation. Blood and tissue samples are collected for biomarker analysis using immunohistochemistry.